EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment of obstructive sleep apnea with CPAP improves daytime sleepiness and fatigue in cancer patients

Kimia G Ganjaei iD, Karen A Wong, Shiela M Strauss, Sigrid V Carlsson, Margaret Barton-Burke, Miranda Tan iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Kimia G Ganjaei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Continuous Positive Airway Pressure, Neoplasms, Fatigue. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fatigue and sleep disorders are prevalent in cancer patients. Obstructive sleep apnea (OSA) commonly causes excessive daytime sleepiness (EDS) and fatigue. We hypothesize that treating cancer patients with OSA using positive airway pressure (PAP) will improve EDS and fatigue.

Methods

A retrospective chart review of sleep clinic visits of cancer patients with newly diagnosed OSA was performed. Epworth Sleepiness Scale (ESS) and fatigue reported at baseline and within 6 months of starting PAP therapy were compared between PAP‐adherent and PAP‐non‐adherent patients.

Results

65 cancer patients with OSA and ESS >10 were recommended PAP therapy, including 45 patients with fatigue. 29 patients pursued PAP therapy with 79% ( n = 23) adherent at follow‐up. The median baseline apnea hypopnea index (AHI) for OSA was 24.0 (interquartile range [IQR] 14.3, 32.3) and 23.8 (IQR 10.1, 42.8) events/hour among PAP‐adherent and PAP‐non‐adherent patients, respectively ( p = 0.90). Median baseline ESS was 14.0 (IQR 12.0, 17.0) among adherent and 17.0 (IQR 11.0, 17.3) among non‐adherent patients ( p = 0.73). The median ESS at follow‐up of the adherent and non‐adherent groups was 8.0 (IQR 6.0, 10.0) and 11.0 (IQR 8.0, 15.8), respectively ( p = 0.08). Median ESS change was −5.0 (IQR −7.0, −4.0) in PAP adherent patients and −2.5 (IQR −5.25, −1.50) in PAP‐non‐adherent patients ( p = 0.07). When the groups are examined separately, the median change in the PAP‐adherent group was highly significant ( p = 0.001), while the ESS median change in the PAP‐non‐adherent group was considerably less ( p = 0.04). 17 out of the 21 PAP‐adherent patients reporting fatigue at baseline indicated improvement at follow‐up.

Conclusions

PAP therapy for OSA in cancer patients improves EDS and fatigue. Larger studies are necessary to evaluate the efficacy of PAP in improving fatigue in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveContinuous Positive Airway PressureNeoplasmsFatigueHumansMaleFemaleMiddle AgedRetrospective StudiesAgedTreatment OutcomeDisorders of Excessive SomnolenceAdultSleepinessPatient Compliance

Stichwörter der Autor:innen

cancerfatigueobstructive sleep apneapap therapysleepiness

Autor:innen und Institutionen

  • Pulmonary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • NYU Rory Meyers College of Nursing, New York, New York, USA.
  • Department of Nursing Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Kimia G Ganjaei, Miranda Tan

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Ganjaei, K. G., Wong, K. A., Strauss, S. M., Carlsson, S. V., Barton-Burke, M., & Tan, M. (2024). Treatment of obstructive sleep apnea with CPAP improves daytime sleepiness and fatigue in cancer patients. Cancer Medicine. https://doi.org/10.1002/cam4.7198

Vancouver

Ganjaei KG, Wong KA, Strauss SM, Carlsson SV, Barton-Burke M, Tan M. Treatment of obstructive sleep apnea with CPAP improves daytime sleepiness and fatigue in cancer patients. Cancer Medicine. 2024. doi:10.1002/cam4.7198

BibTeX
@article{Ganjaei2024,
  author = {Ganjaei, Kimia G and Wong, Karen A and Strauss, Shiela M and Carlsson, Sigrid V and Barton-Burke, Margaret and Tan, Miranda},
  title = {Treatment of obstructive sleep apnea with CPAP improves daytime sleepiness and fatigue in cancer patients},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7198}
}
Kostenlos starten →